(Q48181858)

9 February 2018

title

Intraventricular Delivery of siRNA Nanoparticles to the Central Nervous System (English)

1 reference

9 February 2018

0 references

5

1 reference

9 February 2018

author name string

Rishab Shyam

1

1 reference

9 February 2018

Yong Ren

2

1 reference

9 February 2018

Jason Lee

3

1 reference

9 February 2018

Kerstin E Braunstein

4

1 reference

9 February 2018

Philip C Wong

6

1 reference

9 February 2018

publication date

12 May 2015

1 reference

9 February 2018

Molecular Therapy. Nucleic acids

published in

1 reference

9 February 2018

volume

4

1 reference

9 February 2018

page(s)

e242

1 reference

9 February 2018

Alzheimer's disease: the challenge of the second century

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Alzheimer's disease: analyzing the missing heritability

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

A three-dimensional human neural cell culture model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Protein aggregation diseases: pathogenicity and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Modeling an anti-amyloid combination therapy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

β-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Delivery materials for siRNA therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Recent developments in nanoparticle-based siRNA delivery for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Safety and efficacy of RNAi therapy for transthyretin amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Spherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastoma

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Antisense reduction of tau in adult mice protects against seizures

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression.

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Branched and linear poly(ethylene imine)-based conjugates: synthetic modification, characterization, and application

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Polyethylenimines for siRNA and miRNA delivery in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Acid-responsive linear polyethylenimine for efficient, specific, and biocompatible siRNA delivery

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Targeting the blind spot of polycationic nanocarrier-based siRNA delivery

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Dual-sensitive micellar nanoparticles regulate DNA unpacking and enhance gene-delivery efficiency.

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Recent advances in nanoparticle-mediated siRNA delivery

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Characterization of the temporo-spatial effects of chronic bilateral intrahippocampal cannulae on interleukin-1beta.

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

The effects of polymeric nanostructure shape on drug delivery

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

The effect of particle design on cellular internalization pathways

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

RNAi-microsponges form through self-assembly of the organic and inorganic products of transcription

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

In silico design and enzymatic synthesis of functional RNA nanoparticles.

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Co-transcriptional assembly of chemically modified RNA nanoparticles functionalized with siRNAs.

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Plasmid-templated shape control of condensed DNA-block copolymer nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Alzheimer's disease and other dementias: advances in 2013.

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions.

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Single-stranded siRNAs activate RNAi in animals

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Shape effects of filaments versus spherical particles in flow and drug delivery

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Enhanced gene expression promoted by the quantized folding of pDNA within polyplex micelles

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis

1 reference

https://api.crossref.org/works/10.1038%2FMTNA.2015.15

7 January 2021

Identifiers

DOI

10.1038/MTNA.2015.15

1 reference

9 February 2018

1 reference

9 February 2018